Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 11:38 a.m.

    📋 IVERIC bio, Inc. (ISEE) - Clinical Trial Update

    Filing Date: 2022-07-05

    Accepted: 2022-07-05 07:36:18

    Event Type: Clinical Trial Update

    Event Details:

    IVERIC bio Inc (the company became a subdivision of the company Astellas Pharma Inc. (TSE: 4503)) (ISEE) Announces Clinical Trial Update IVERIC bio Inc (the company became a subdivision of the company Astellas Pharma Inc. (TSE: 4503)) (ISEE) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: plan, invest
    • Diseases/Conditions: Zimura
    • Collaboration: Iveric Bio

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: IVERIC bio Inc (the company became a subdivision of the company Astellas Pharma Inc. (TSE: 4503))
    • CIK: 0001410939
    • Ticker Symbol: ISEE
    • Period End Date: 2022-06-30
    • Document Type: 8-K

Search

News categories